Zobrazeno 1 - 10
of 63
pro vyhledávání: '"59"'
Publikováno v:
Neuro-Oncology
OBJECTIVE To explore the efficacy and safety of en bloc resection therapy on posterior fossa tumor in children. METHODS A retrospective analysis was conducted on the clinical data of 94 patients with posterior fossa tumor admitted to Department of Pe
Autor:
Florien W. Boele, Quirien Oort, Linda Dirven, Jaap C. Reijneveld, Andrea Talacchi, Teresa Young, Robin Grant, H. Sato, Martin J B Taphoorn
Publikováno v:
Neuro Oncol
BACKGROUND In brain tumour patients, impairments in every day functioning can impact quality of life, and are therefore an important outcome in both clinical trials and practice. One way to measure every day functioning is with an activities of daily
Publikováno v:
Neuro-Oncology. 19:iii88-iii88
OBJECTIVES: To investigate the progression-free (PFS) and overall survival (OS) in patients ≥60 years old referred with a presumed diagnosis of low grade glioma (LGG). DESIGN: Neuro-oncology MDT outcomes from a single institution between 1/1/2009 a
Autor:
Brandon W. Smith, Nicholas F Hug, Maryam Mohammadzadeh, Kristen W. Yeom, Michael Zhang, Sandip Biswal, Robert J. Spinner, Sandy Napel, Elizabeth Tong, Mark A. Mahan, Courtney Pendleton, Vaishnavi Rao, Jayne Seekins, Thomas J. Wilson, Sam Wong, Forrest Hamrick
Publikováno v:
Neuro Oncol
Background Non-invasive differentiation between schwannomas and neurofibromas is important for appropriate management, preoperative counseling, and surgical planning, but has proven difficult using conventional imaging. The objective of this study wa
Autor:
Zhiyong Qin, Lingchao Chen, Jingtao Nie, Junrui Chen, Kun Song, Yang Wang, Dongxiao Zhuang, Jinsong Wu, Yu Yao
Publikováno v:
Neuro-Oncology. 23:vi154-vi155
OBJECTIVES Tumor Treating Fields (TTFields) has been approved for the treatment of newly diagnosed and relapsed glioblastoma(GBM)in China in 2020. Only few TTFields data in Asia patients were reported. This retrospective analysis is aimed at inve
Autor:
Caterina Giannini, Felice Giangaspero
Publikováno v:
Neuro Oncol
BACKGROUND: Isocitrate dehydrogenase (IDH) wildtype (wt) grade II gliomas are a rare and heterogeneous entity. Survival and prognostic factors are poorly defined. METHODS: We searched retrospectively all patients diagnosed with diffuse World Health O
Autor:
Matthew Williams, K Le-Calvez, Lillie Pakzad-Shahabi, W Mohammed, S Mistry, Seema Dadhania, Waqar Saleem
Publikováno v:
Neuro Oncol
BACKGROUND In patients with High Grade Glioma (HGG), QoL and physical function decline with progressive disease (PD). Objective assessment of physical functioning is challenging as patients spend most of their time away from the hospital. Wearable te
Autor:
Bertrand Mathon, Khê Hoang-Xuan, Jean-Yves Delattre, Marine Giry, Susanna Ronchi, Alice Laurenge, Marc Sanson, Laurent Capelle, Karima Mokhtari, Chiara Villa, Franck Bielle, Giulia Berzero, Yannick Marie, Yohann Schmitt, Anna Luisa Di Stefano, Ahmed Idbaih, Erell Guillerm
Publikováno v:
Neuro Oncol
Background Isocitrate dehydrogenase (IDH) wildtype (wt) grade II gliomas are a rare and heterogeneous entity. Survival and prognostic factors are poorly defined. Methods We searched retrospectively all patients diagnosed with diffuse World Health Org
Autor:
Naomi Fersht, John Tazare, John Gregson, Nicholas F. Brown, Neil Kitchen, Paul Mulholland, Diego Ottaviani, Sebastian Brandner
Publikováno v:
Neuro-Oncology. 23:vi16-vi16
INTRODUCTION Glioblastoma has limited therapeutic options and is associated with a poor prognosis. Treatment, clinical outcomes, and prognostic factors remain poorly characterised outside of the selected population enrolled in clinical trials. METHOD
Autor:
Mary Lou Affronti, Henry S. Friedman, David Casarett, Katherine B. Peters, Margaret Johnson, Luis Ramirez, Mustafa Khasraw, Jung-Young Kim, Daniel Landi, David M. Ashley, James E. Herndon, Eric S. Lipp, A. Desjardins, Nicole Cort
Publikováno v:
Neuro-Oncology. 23:vi189-vi189
INTRODUCTION There is increasing recognition that palliative care (PC) can benefit patients with advanced cancers. However, early referral to PC is not yet a reality for patients diagnosed with a primary brain tumor. We hypothesize that lack of knowl